Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-26-080417
Filing Date
2026-07-22
Accepted
2026-07-22 16:30:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0298644-8k425_inmed.htm 425 32207
2 AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT, DATED AS OF JULY 22, 2026, BY ea029864401ex10-1.htm EX-10.1 64168
3 PRESS RELEASE, ISSUED ON JULY 22, 2026 ea029864401ex99-1.htm EX-99.1 15672
  Complete submission text file 0001213900-26-080417.txt   113662
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filed by) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Subject) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 425 | Act: 34 | File No.: 001-39685 | Film No.: 261194021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)